Medpace Holdings, Inc. (MEDP) FY2026 Q2 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
Medpace Holdings, Inc. (MEDP) FY2026 Q2 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 2,057,181,000 US dollars
- Current assets
- 1,050,285,000 US dollars
- Non-current assets
- 1,006,896,000 US dollars
- Liabilities
- 1,623,320,000 US dollars
- Current liabilities
- 1,435,429,000 US dollars
- Non-current liabilities
- 187,891,000 US dollars
- Equity
- 433,861,000 US dollars
- Cash and cash equivalents
- 502,688,000 US dollars
- Accounts receivable and unbilled, net (includes $2.9 million and $3.5 million with related parties at June 30, 2026 and December 31, 2025, respectively)
- 441,797,000 US dollars
- Prepaid expenses and other current assets
- 105,800,000 US dollars
- Goodwill
- 662,396,000 US dollars
- Property and equipment, net
- 157,114,000 US dollars
- Operating lease right-of-use assets
- 125,849,000 US dollars
- Intangible assets, net
- 33,110,000 US dollars
- Other assets
- 25,196,000 US dollars
- Deferred income taxes
- 3,231,000 US dollars
- Advanced billings (includes $13.1 million and $12.3 million with related parties at June 30, 2026 and December 31, 2025, respectively)
- 904,722,000 US dollars
- Accrued expenses
- 451,076,000 US dollars
- Other current liabilities
- 42,104,000 US dollars
- Accounts payable (includes $0.1 million and $0.3 million with related parties at June 30, 2026 and December 31, 2025, respectively)
- 37,527,000 US dollars
- Operating lease liabilities
- 120,100,000 US dollars
- Other long-term liabilities
- 59,584,000 US dollars
- Deferred income tax liability
- 8,207,000 US dollars
- Additional paid-in capital
- 964,183,000 US dollars
- Common stock - $0.01 par-value; 250,000,000 shares authorized at June 30, 2026 and December 31, 2025; 27,910,605 and 28,370,780 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
- 279,000 US dollars
- Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025
- 0 US dollars
- Accumulated deficit
- negative 511,368,000 US dollars
- Treasury stock - 69,593 and 69,623 shares at June 30, 2026 and December 31, 2025, respectively
- negative 12,151,000 US dollars
- Accumulated other comprehensive loss
- negative 7,082,000 US dollars
- Gross equity (calculated)
- 964,462,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
